A Randomised, Double-Blind, Placebo-Controlled, First-in-human Phase I Study to Characterise the Safety, Pharmacokinetics and Immunogenicity of 9MW1411 in Healthy Chinese Subjects.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS（2024）
Key words
9mw1411,Staphylococcus aureus,Alpha toxin,Monoclonal antibody,Pharmacokinetics,First-in-human study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined